These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34940832)

  • 1. Mechanistic diversity in MHC class I antigen recognition.
    Barbosa CRR; Barton J; Shepherd AJ; Mishto M
    Biochem J; 2021 Dec; 478(24):4187-4202. PubMed ID: 34940832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.
    Ge Q; Stone JD; Thompson MT; Cochran JR; Rushe M; Eisen HN; Chen J; Stern LJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13729-34. PubMed ID: 12374859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor.
    Clement M; Knezevic L; Dockree T; McLaren JE; Ladell K; Miners KL; Llewellyn-Lacey S; Rubina A; Francis O; Cole DK; Sewell AK; Bridgeman JS; Price DA; van den Berg HA; Wooldridge L
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34272276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome-Generated
    Mansurkhodzhaev A; Barbosa CRR; Mishto M; Liepe J
    Front Immunol; 2021; 12():614276. PubMed ID: 33717099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling.
    Anikeeva N; Gakamsky D; Schøller J; Sykulev Y
    PLoS One; 2012; 7(8):e41466. PubMed ID: 22870225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors.
    Macdonald IK; Harkiolaki M; Hunt L; Connelley T; Carroll AV; MacHugh ND; Graham SP; Jones EY; Morrison WI; Flower DR; Ellis SA
    PLoS Pathog; 2010 Oct; 6(10):e1001149. PubMed ID: 20976198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers.
    Szeto C; Lobos CA; Nguyen AT; Gras S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms.
    Smith TR; Verdeil G; Marquardt K; Sherman LA
    J Immunol; 2014 Oct; 193(7):3409-16. PubMed ID: 25156361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
    Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
    J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity.
    Engels B; Chervin AS; Sant AJ; Kranz DM; Schreiber H
    Mol Ther; 2012 Mar; 20(3):652-60. PubMed ID: 22233579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
    Margalit A; Fishman S; Berko D; Engberg J; Gross G
    Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides.
    Siewert K; Malotka J; Kawakami N; Wekerle H; Hohlfeld R; Dornmair K
    Nat Med; 2012 May; 18(5):824-8. PubMed ID: 22484809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL.
    Busch DH; Pamer EG
    J Immunol; 1998 May; 160(9):4441-8. PubMed ID: 9574549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition surfaces of MHC class I.
    Jones EY; Tormo J; Reid SW; Stuart DI
    Immunol Rev; 1998 Jun; 163():121-8. PubMed ID: 9700505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperone-mediated MHC-I peptide exchange in antigen presentation.
    Jiang J; Natarajan K; Margulies DH
    IUCrJ; 2024 May; 11(Pt 3):287-298. PubMed ID: 38656309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell antigen receptor recognition of antigen-presenting molecules.
    Rossjohn J; Gras S; Miles JJ; Turner SJ; Godfrey DI; McCluskey J
    Annu Rev Immunol; 2015; 33():169-200. PubMed ID: 25493333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.